Participants 21 74 3
docosahexaenoic acid in X-linked retinitis pigmentosa
Participants 294 364 3
slow vision loss in patients with X-linked retinitis pigmentosa (XLRP)
Participants 686 750 5
Males (n = 78; 7-31 years) meeting entry criteria were enrolled.
